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a  b  s  t  r  a  c  t
Voxel-based  Morphometry  (VBM)  is  a widely  used  automated  technique  for the  analysis  of neuroanato-
mical  images.  Despite  its popularity  within  the  neuroimaging  community,  there  are  outstanding  concerns
about  its potential  susceptibility  to false  positive  ﬁndings.  Here  we  review  the main  methodological  fac-
tors  that  are  known  to inﬂuence  the  results  of  VBM  studies  comparing  two  groups  of subjects.  We  then
use  two  large,  open-access  data  sets  to empirically  estimate  false  positive  rates  and  how  these  depend
on  sample  size,  degree  of  smoothing  and  modulation.  Our  review  and  investigation  provide  three  main
results:  (i) when  groups  of  equal  size  are  compared  false  positive  rate  is  not higher  than  expected,  i.e.
about  5%;  (ii)  the  sample  size,  degree  of  smoothing  and  modulation  do  not  appear  to  inﬂuence  false  pos-
itive  rate;  (iii)  when  they  exist,  false  positive  ﬁndings  are  randomly  distributed  across  the  brain.  These
results  provide  reassurance  that  VBM  studies  comparing  groups  are  not  vulnerable  to  the  higher  than
expected  false  positive  rates  that  are  evident  in  single  case  VBM.
© 2015  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Structural magnetic resonance imaging (MRI) allows the non-
invasive and in vivo investigation of brain structure. Over the past
two decades, the development of a number of automated tech-
niques for the analysis of structural MRI  data (Chung et al., 2003;
Mechelli et al., 2005; Bandettini, 2009; Dell’Acqua and Catani, 2012)
has led to a proliferation of studies on the neuroanatomical basis
of neurological and psychiatric disorders. The popularity of these
techniques can be explained by two critical advantages relative to
traditional tracing methods: ﬁrstly, they allow detection of subtle
morphometric group differences in brain structure that may  not
be discernible by visual inspection; secondly, they allow investi-
gation of the entire brain, rather than a particular structure, in an
automatic and objective manner.
The most widely used automated technique for the analysis of
structural brain images is Voxel-based Morphometry (VBM) which
involves a voxel-wise comparison of the local volume or con-
centration of gray and white matter between groups of subjects
(Ashburner and Friston, 2000, 2001; Good et al., 2001; Mechelli
et al., 2005). Over the past 15 years, VBM has been used success-
fully to investigate a wide range of neurological and psychiatric
disorders including, but not limited to, Alzheimer’s disease (Li et al.,
2012), Parkinson’s disease (Pan et al., 2013), multiple sclerosis
(Lansley et al., 2013), unipolar (Lai, 2013) and bipolar (Selvaraj et al.,
2012) depression, anxiety disorders (Radua et al., 2010) and psy-
chosis (Honea et al., 2005; Bora et al., 2011 Mechelli et al., 2011). In
addition, VBM has been used to compare groups of healthy subjects
who differ with respect to biological or environmental variables of
interest such as age (Kennedy et al., 2009; Takahashi et al., 2011),
gender (Takahashi et al., 2011; Sacher et al., 2013), number of spo-
ken languages (Mechelli et al., 2004), and exposure to stressful life
events (Papagni et al., 2011).
1.1. Methodological factors inﬂuencing the results of a VBM study
Although overall VBM can be considered a user-friendly and
practical tool, any user has to navigate a number of methodological
options that are likely to inﬂuence the ﬁnal results. These include,
for example, the protocol for the acquisition of the MRI  data, the
type of pre-processing of the images and the statistical threshold
used to identify signiﬁcant effects.
Firstly, the accuracy and precision of the results are critically
dependent on the quality of the input images including, for exam-
ple, image resolution and acquisition sequence. Higher resolution
is thought to result in more localized and more reliable results
(Iwabuchi et al., 2013); this means that the results of identical
comparisons performed at 1.5 T and 3 T respectively may  differ for
purely methodological reasons. The acquisition sequence is another
source of variability that is often underestimated. Acquisition
sequence includes different parameters such as image-to-noise
ratio and uniformity, which are known to affect tissue classiﬁca-
tion leading to different results (Tardiff et al., 2009; Streitbürger
et al., 2014).
Secondly, the results of a VBM study are dependent on the type
of preprocessing. This may  differ with respect to the segmentation
procedure (Ashburner, 2012), the widely discussed normalization
protocol (Crum et al., 2003; Ashburner and Friston, 2001) and the
Gaussian smoothing kernel applied to the images (Salmond et al.,
2002; Viviani et al., 2007; Smith and Nichols, 2009).
Thirdly, the results of a VBM study depend on the statistical
analysis. For example, while nearly all studies use a correction
for multiple comparisons based on random ﬁeld theory, the user
has the option of choosing the statistical threshold and the num-
ber of statistical tests (Smith and Nichols, 2009; Lieberman and
Cunningham, 2009). In addition, some but not all studies use nui-
sance variables as covariates of no interest to reduced the amount
of unexplained variance in the data (Hu et al., 2011).
From this brief overview, it appears that every step of a VBM
study, from the acquisition of the data to the statistical analysis,
involves a number of methodological choices that are likely to affect
the ﬁnal results.
1.2. Non-normality of the residuals
While the above methodological factors relate to how the data
are acquired and the analyses are carried out, the validity of the ﬁnal
results are also dependent on the characteristics of the data. In par-
ticular, VBM assumes that the error terms in the statistical analysis
are normally distributed; this is ensured through the Central Limit
Theorem by applying a Gaussian smoothing kernel to the data at
the preprocessing stage (Salmond et al., 2002). However, smooth-
ing the data does not always ensure normal distribution of the error
terms (Salmond et al., 2002; Silver et al., 2011; Scarpazza et al.,
2013). For example a previous investigation found that, based on
the Shapiro–Wilks test for normality, residuals in smoothed images
were highly non-normal and, furthermore, deviation from normal-
ity was  inversely related to the smoothing kernel (Silver et al.,
2011). Moreover, in a recent investigation (Scarpazza et al., 2013),
we estimated the likelihood of detecting signiﬁcant differences in
gray matter volume in individuals free from neurological or psychi-
atric diagnosis using two  independent data sets (Scarpazza et al.,
2013). This revealed that, when comparing a single subject against a
group in VBM, the chance of detecting a signiﬁcant difference which
is not related to any psychiatric or neurological diagnosis is much
higher than previously expected. As an example, using a standard
voxel-wise threshold of p < 0.05 (corrected) and an extent threshold
of 10 voxels, the likelihood of a single subject showing at least one
signiﬁcant difference is as high as 93.5% for increases and 71% for
decreases. These results were unlikely to be due solely to the indi-
vidual variability in neuroanatomy; this is because such variability
would inﬂate the standard error estimated from the controls result-
ing in reduced rather than increased sensitivity. The most likely
explanation for the very high false positive rate was  that the data
were not normally distributed; hence, the assumption of normality
of the residuals required by the random ﬁeld theory was  violated.
We  concluded that interpretation of the results of single case VBM
studies should be performed with caution, particularly in the case
of signiﬁcant differences in temporal and frontal lobes where false
positive rates appear to be highest.
The above investigation raises the question of whether the sur-
prisingly high false positive rate in single case VBM studies would
also be evident in the context of balanced designs in which groups
of equal size are compared. Although it is traditionally assumed that
the use of smoothing is enough to ensure normality of the resid-
uals when comparing groups of equal size (Mechelli et al., 2005),
there is preliminary evidence that residuals in smoothed images
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can still be non-normal and that this may  result in high false posi-
tive rates even in the context of balanced designs (Salmond et al.,
2002; Silver et al., 2011). A higher-than-expected false positive rate
would have important implications for the validity of the hundreds
of VBM studies comparing different experimental groups that are
being published each year; conversely, a false positive rate of up to
5% (for a one-tailed test) or 10% (for a two-tailed test) would provide
reassurance that any signiﬁcant differences in group VBM studies
is unlikely to result from the interaction between non-normality of
the residuals and random ﬁeld theory. So, the outstanding question
which needs to be addressed is: should we be worried?
1.3. An experimental contribution to the existing literature
Since a revision of the existing literature is not sufﬁcient to
answer the above question, we decided to add an experimental con-
tribution in which we examined false positive rates in group VBM
studies by empirically estimating the likelihood of detecting signif-
icant differences in gray matter volume (GMV) between groups of
the same size comprising of healthy individuals. In order to maxi-
mize the generalizability of our results, we used two independent
data sets (Biswal et al., 2010) consistent with our previous investi-
gation of false positive rates in single case VBM studies (Scarpazza
et al., 2013). These two freely available data sets were acquired
with the same images resolution (3 T) and acquisition sequence
(MPRAGE) and comprised of a total of 396 subjects free from neu-
rological or psychiatric diagnosis. A similar procedure to the one
described in Scarpazza et al. (2013) was adopted, with the only
difference being that in the present investigation we compared
two groups of equal size rather than a single subject to a group.
The impact of sample size (n = 8, 12, 16), smoothing (4 mm,  8 mm,
12 mm)  and modulation (with and without modulation) was  also
investigated, as these factors have been found to inﬂuence false
positive rates in previous studies (Salmond et al., 2002; Viviani
et al., 2007; Silver et al., 2011; Scarpazza et al., 2013).
Our ﬁrst hypothesis was that when VBM is used to compare
groups of equal size, the rate of false positives would be about 5%
(for one-tailed tests) or 10% (for two-tailed tests), in contrast with
the very high false positive rates observed in the context of unbal-
anced designs (Scarpazza et al., 2013). Our second hypothesis was
that false positive rate would vary as a function of sample size (with
a higher number of differences detected for smaller sample size),
degree of smoothing applied to the data (with a higher number of
differences detected for smaller kernel smoothing), and modula-
tion (with a higher number of differences detected for unmodulated
data) as these variables have been reported to affect the number of
signiﬁcant effects in previous studies (Salmond et al., 2002; Viviani
et al., 2007; Smith and Nichols, 2009; Scarpazza et al., 2013). Our
third hypothesis was that, consistent with the results of our previ-
ous work (Scarpazza et al., 2013), signiﬁcant differences would not
be equally distributed across the whole brain but would be mainly
located in the frontal and temporal lobes.
2. Methods
2.1. Subjects
Data from the Neuroimaging Informatics Tools and Resources
Clearinghouse (NITRC) which are available at http://fcon 1000.
projects.nitrc.org/fcpClassic/FcpTable.html were used (Biswal
et al., 2010). The Cambridge (MA, USA) and Beijing (China) data
sets were chosen because of their large sample size (n = 198) and
their matched age range (18–28). All participants have never
received a neurological or psychiatric diagnosis.
2.2. MRI data acquisition
All participants underwent the acquisition of a structural
MRI  scan using a 3 T MRI  system. A T1-Weighted sagittal
three-dimensional magnetization-prepared rapid gradient echo
(MPRAGE) sequence was  acquired, covering the entire brain. For
the acquisition of the Cambridge data set, the following parameters
were used: TR = 3; 144 slices, voxel resolution 1.2, 1.2, 1.2; matrix
192 × 192. For the acquisition of the Beijing data set, the following
parameters were used: TR = 2; 128 slices, voxel resolution 1.0, 1.0,
1.3; matrix 181 × 175.
2.3. Data analysis
2.3.1. Preprocessing
Images were checked for scanner artifacts, and gross anatomi-
cal abnormalities, and then reoriented along the anterior–posterior
commissure (AC–PC) line with the AC set as the origin of the spa-
tial coordinates. The new segmentation procedure implemented in
SPM8 (http://www.ﬁl.ion.ucl.ac.uk/spm), running under Matlab 7.1
(Math Works, Natick, MA,  USA) was  used to segment all the images
into gray matter (GM) and white matter (WM).  A fast diffeomor-
phic image registration algorithm (DARTEL; Ashburner, 2007) was
used to warp the GM partitions into a new study-speciﬁc reference
space representing an average of all the subjects included in the
analysis (Ashburner and Friston, 2009; Yassa and Stark, 2009). As
an initial step, two different templates (one for each data set) and
the corresponding deformation ﬁelds, required to warp the data
from each subject to the new reference space, were created using
the GM partitions (Ashburner and Friston, 2009). Each subject-
speciﬁc deformation ﬁeld was then used to warp the corresponding
GM partition into the new reference space with the aim of maxi-
mizing accuracy and sensitivity (Yassa and Stark, 2009). Images
were, ﬁnally, afﬁne transformed into Montreal Neurological Insti-
tute (MNI) space and smoothed with a 4, 8 and 12-mm full-width at
half-maximum (FWHM) Gaussian kernel. The above procedure was
followed twice to create both unmodulated and modulated images,
which were analyzed separately. The analysis on unmodulated data
was performed on groups with sample size 16 and smoothing 8 mm
only, consistent with our previous investigation (Scarpazza et al.,
2013).
2.3.2. Group comparisons
Using SPM8, for each data set we  performed 300 group compar-
isons including 100 comparisons between 2 groups of 16 subjects;
100 comparisons between 2 groups of 12 subjects; and 100 com-
parisons between 2 groups of 8 subjects. The groups used in all
comparisons were created using randomization as implemented in
Microsoft Excel software. A sample size of 8, 12 and 16 was cho-
sen for three main reasons. Firstly, a typical neuroimaging study of
regional differences includes 8–16 subjects per experimental group
(Friston et al., 1999). Secondly, a recent analysis of the effect size
in classical inference has suggested that, in order to optimize the
sensitivity to large effects while minimizing the risk of detecting
trivial effects, the sufﬁcient sample size for a study is 16 (Friston,
2012); this investigation also highlighted the common misconcep-
tion that smaller sample sizes lead to higher false positives rates.
Thirdly, we  wanted to examine the impact of decreasing sample
size since parametric statistics appear to be more prone to devi-
ation from normality for smaller sample sizes (Salmond et al.,
2002; Scarpazza et al., 2013). In all comparisons, age and gender
were entered into the design matrix as covariates of no interest.
Voxels outside the brain were excluded by employing an implicit
mask that removed all voxels whose intensity fell below 20% of the
mean image intensity. The proportional scaling option was used to
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identify regionally speciﬁc changes that were not confounded by
global differences.
2.3.3. Statistical analysis
For each group comparison, two two-sample t-tests were used
to identify increases and decreases in one group relative to the other
respectively. Statistical inferences were made at voxel-level using
a threshold of p < 0.05 with family-wise error (FWE) correction for
multiple comparisons across the whole brain. No extent threshold
was used since the main aim of the current investigation was  to
quantify the number of false positive results irrespective of cluster
size. When signiﬁcant between-group differences were detected,
we refer to Group 1 > Group 2 to indicate increased GM volume in
Group 1 compared to Group 2, while we refer to Group 1 < Group 2
to indicate decreased GM volume in Group 1 compared to Group 2.
For each data source (Beijing and Cambridge), we  counted the
number of comparisons yielding statistically signiﬁcant differences
(out of 100) over the three smoothing kernels (4, 8 and 12 mm),
three sample sizes (16, 12 and 8 subjects per group), two pre-
processing types (modulated, unmodulated) and two  directions
(Group 1 > Group 2; Group 1 < Group 2).
In order to investigate whether smoothing, sample size and
direction had a signiﬁcant impact on the number of false posi-
tive rates in the context of modulated data, we used the Statistical
Package for the Social Sciences 22.0 (IBM SPSS Statistics 22.0,
Chicago, IL, USA) to ﬁt a logistic regression model from each data
source, using the presence of a statistically signiﬁcant difference in
each comparison (yes or no) as dependent variable, and smooth-
ing, sample size and direction as independent variables. For 8 mm
smoothing and sample size of 16 subjects both modulated and
unmodulated data were available, and therefore we also ﬁt a fur-
ther logistic regression model; here the dependent variable was the
presence of a statistically signiﬁcant difference in each compari-
son (yes or no), and the independent variables were modulation
and direction (with only 8 mm smoothing and a sample size of 16
subjects, smoothing and sample size were not modeled). Both logis-
tic regression models were assessed using the Hosmer–Lemeshow
goodness-of-ﬁt test, where a statistically signiﬁcant p-value indi-
cates lack-of-ﬁt.
2.3.4. Brain areas individuation
From the SPM output, i.e. the list of MNI  coordinates of the
areas showing signiﬁcant increases or decreases, we  derived the
corresponding areas using the Automated Anatomical Labeling
(AAL) atlas as implemented in PickAtlas software (http://fmri.
wfubmc.edu/software/PickAtlas).
3. Results
3.1. Number of comparisons yielding signiﬁcant differences
When differences in each direction where considered separately
(one-tailed), the number of comparisons yielding at least one false
positive result was no more than 5% regardless of the sample size
used and smoothing applied, consistent with our prediction for
one-tailed tests. This was the case for both data sets, see Table 1
for details. When differences in the two directions were combined
(two-tailed), the number of comparisons yielding at least one false
positive result in either direction was no more than 10%, consistent
with our prediction for two-tailed tests. Again, this was  the case for
both data sets, see Table 1 for details.
3.2. Impact of smoothing, sample size and direction of effect
The Hosmer–Lemeshow test was not signiﬁcant (p = 0.915 and
p = 0.953 for the Beijing and Cambridge data sets respectively), con-
sistent with a null hypothesis of good model ﬁt.
The impact of smoothing on the false positive rate was not sig-
niﬁcant, in either the Beijing (p = 0.178) or the Cambridge (p = 0.162)
data set. Similarly, the impact of sample size on the false posi-
tive rate was  not signiﬁcant, in either the Beijing (p = 0.847) or the
Cambridge (p = 0.162) data set. Finally, as one would expect given
that all groups were created using randomization, the number of
false positives did not vary depending on the direction of the effect
under consideration (i.e. Group 1 > Group 2 or Group 1 < Group 2);
this was  the case both for the Beijing (p = 0.636) and the Cambridge
(p = 0.192) data sets. Overall, these results indicate that smoothing,
sample size and direction of the effect under investigation had no
effect on the number of signiﬁcant differences in the two  data sets.
3.3. Impact of modulation
The Hosmer–Lemeshow test was  not signiﬁcant (p = 0.153 and
p = 0.669 for the Beijing and Cambridge data sets, respectively),
consistent with a null hypothesis of good model ﬁt.
The impact of modulation on the false positive rate was  not sig-
niﬁcant, in either the Beijing (p = 1) or the Cambridge (p = 0.760)
data set.
3.4. Likelihood of detecting local maxima in a speciﬁc region
In addition to the number of comparisons yielding signiﬁcant
results, we also considered the location of the signiﬁcant clusters
(reported as absolute number in brackets in Table 1). With respect
to comparisons performed on modulated images only, and pooling
all the results obtained with different sample size and smoothing,
55 clusters were identiﬁed in the Beijing data set (2 of which out of
the brain and then removed from the following statistics), and 50
clusters in the Cambridge data set (1 of which out of the brain and
then removed from the following statistics). The signiﬁcant differ-
ences were distributed throughout the cortex (44 clusters out of
53, 82.7% of the total ﬁndings in Beijing data set and 41 clusters
out of 49, 83.6% of the total ﬁndings in Cambridge data set) with
very few differences detected in subcortical regions (1 cluster in
each data set, 1.8% and 2% in the Beijing and Cambridge data sets
respectively). Additional differences were detected in the cingulate
cortex (2 clusters out of 53, 3.8% of the total ﬁndings in the Beijing
data set and 4 clusters out of 49, 8.1% of the total ﬁndings in the
Cambridge data set), the insula (1 cluster only, 1.8% of the total
ﬁndings, in the Cambridge data set) and the cerebellum (6 clusters
out of 53, 11.3% of the total ﬁndings in the Beijing data set and 2
clusters out of 49, 4% of the total ﬁndings in the Cambridge data set).
These results are summarized in Table 2 and represented graphi-
cally in Fig. 1; in addition, the location of each signiﬁcant cluster
can be found in the Supplementary Material.
Moreover, we  observed that the signiﬁcant differences were
mainly located in the frontal lobe (21 clusters out of 53, 39.6% of
the total ﬁndings in the Beijing data set and 16 clusters out of 49,
32.6% of the total ﬁndings in the Cambridge data set) compared to
the other lobes (parietal: 10/53, 18.8% and 9/49, 18.3% in the Bei-
jing and Cambridge data sets respectively; temporal: 4/53, 7.4% and
12/49, 24%; occipital: 9/53, 16.9% and 4/49, 8.1%).
In order to investigate whether the larger number of false posi-
tives in the frontal lobe relative to other regions of the brain could
be explained by differences in size (Semendeferi et al., 1997), we
estimated the volume (mm3 and percentage) of each region of
interest reported in Table 2 using PickAtlas. We then used the z
test as implemented in SPSS (IBM SPSS Statistics 22.0, Chicago, IL,
USA) to investigate whether the number of false positives in each
region was  proportional to the regional volume. The z test revealed
that, in each region of interest, the number of false positives was
proportional to the regional volume (p > 0.05). Output tables for
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Table  1
Number of signiﬁcant differences. Numbers of comparisons yielding statistically signiﬁcant differences between groups as a function of smoothing (4 mm,  8 mm,  12 mm),
sample  size (n = 8, 12, 16) and modulation (modulated, unmodulated); as some comparisons yielded more than one signiﬁcant difference, the total number of clusters across
all  comparisons is also reported in brackets. We report this information for increases and decreases separately (Group 1 > Group 2, Group 1 < Group 2) as well in combination
(total).  All differences were identiﬁed using a statistical threshold of p < 0.05 (FWE corrected).
4 mm 8 mm 12 mm
Group
1 > Group 2
Group
1 < Group 2
Total Group
1 > Group 2
Group
1 < Group 2
Total Group
1 > Group 2
Group
1 < Group 2
Total
16 vs 16 Modulated Beijing 4 (7) 2 (3) 6 (10) 3 (5) 1 (1) 4 (6) 3 (7) 3 (3) 6 (10)
Cambridge 1 (1) 0 (0) 1 (1) 2 (2) 3 (3) 5 (5) 1 (1) 4 (5) 5 (6)
12  vs 12 Modulated Beijing 4 (4) 3 (3) 7 (7) 0 (0) 2 (2) 2 (2) 1 (1) 0 (0) 1 (1)
Cambridge 2 (3) 2 (2) 4 (5) 1 (1) 2 (2) 3 (3) 1 (1) 1 (1) 2 (2)
8  vs 8 Modulated Beijing 3 (3) 3 (3) 6 (6) 2 (2) 3 (3) 5 (5) 2 (4) 3 (4) 5 (8)
Cambridge 1 (2) 3 (3) 4 (5) 2 (6) 3 (3) 5 (9) 4 (9) 5 (5) 9 (14)
16  vs 16 Unmodulated Beijing 1 (1) 3 (3) 4 (4)
Cambridge 4 (5) 2 (2) 6 (7)
Table 2
The table reported the volume in mm3 of each cerebral region. The percentage has been calculated on a total of 1583 mm3 of total intracranial volume. Absolute number and
proportion of statistically signiﬁcant differences in different cortical and subcortical areas were reported for Beijing and Cambridge data sets, separately.
Volume (mm3) % Beijing (n = 53 clusters) Cambridge (n = 49 clusters)
Raw number % Raw number %
Frontal lobe 562.6 35.5 21 39.6 16 32.6
Parietal lobe 214.8 13.51 10 18.8 9 18.3
Temporal lobe 258.7 16.29 4 7.4 12 24
Occipital lobe 170.6 10.73 9 16.9 4 8.1
Insula 29 1.83 0 – 1 2
Cingulate 61.2 3.85 2 3.7 4 8.1
Subcorical structures 89.7 5.62 1 1.8 1 2
Cerebellum 196.9 12.38 6 11.3 2 4
Outside the brain (2) (1)
Beijing and Cambridge respectively are reported in Supplementary
Material (Tables S2 and S3).
Moreover, in order further explore the association between
number of false positives and regional volume, we estimated Spear-
man’s correlations for the two data sets separately. The correlations
were signiﬁcant both in the Beijing (R = 0.80, p = 0.01) and the
Cambridge (R = 0.84, p = 0.008) data sets. These results are repre-
sented graphically in the Supplementary Material (Fig. S2).
4. Discussion
Previous investigations have used VBM to investigate brain
abnormalities in a wide range of neurological and psychiatric
disorders (Mechelli et al., 2005). However, previous simulations
suggest that this technique may  be susceptible to high false positive
rates, particularly when the residuals are not normally distributed
(Salmond et al., 2002; Scarpazza et al., 2013). The present study
Fig. 1. Localization of statistically signiﬁcant clusters in the Beijing (A) and Cambridge (B) data sets across all statistical analyses with modulated images. This image was
created  for illustration purposes using coordinate-based ROIs with 10 mm radius, with the center of each ROI located in the local maxima of the corresponding cluster. The
10  mm radius was chosen for display purposes in order to make each cluster clearly visible.
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aimed to investigate whether the surprisingly high false positive
rates found in single case VBM studies would also be evident in
VBM studies in which groups of equal size are compared. This was
achieved by empirically estimating the likelihood of detecting sig-
niﬁcant differences when comparing groups of healthy subjects in
two independent, freely available data sets. Such empiricism was
preferred to a simulation-based approach given recent evidence
demonstrating a discrepancy in results between real and simulated
neuroimaging data (Silver et al., 2011).
We  tested three hypotheses based on the existing literature:
ﬁrstly, we hypothesized that false positive rates would be about
5% (for one-tailed t test), in contrast with the very high false posi-
tive rates observed in the context of single case VBM; secondly, we
expected that false positive rates would vary as a function of sam-
ple size (with a higher number of differences detected for smaller
sample size), degree of smoothing applied to the data (with a higher
number of differences detected for smaller kernel smoothing), and
modulation (with and without modulation); thirdly, we hypothe-
sized that signiﬁcant differences would be mainly located in the
frontal and temporal lobes.
Concerning the ﬁrst hypothesis, when increases (i.e. Group
1 > Group 2) and decreases (i.e. Group 1 < Group 2) were consid-
ered separately, we detected a false positive rate of less than 5%.
Critically, this result was replicated using two independent data
sets acquired from subjects of different ethnicities, using differ-
ent scanners, and different acquisition sequences. Therefore, our
ﬁrst hypothesis was conﬁrmed: in VBM with balanced designs the
likelihood of detecting a signiﬁcant difference is not higher than
expected. This provides reassurance that, when groups of equal
size are compared, VBM is not susceptible to the violation of the
assumption of normality that is responsible for high false positive
rates in single case VBM (Scarpazza et al., 2013).
In contrast with our second hypothesis, we found that the num-
ber of false positives is not affected by the degree of smoothing,
sample size or modulation. The null effect of smoothing replicates
a previous investigation reporting that, in the context of balanced
group comparisons, smoothing at 4 mm is sufﬁcient to ensure
that any non-normality has minimal impact on false positive rate
(Salmond et al., 2002). In contrast, smoothing is not sufﬁcient to
prevent an escalation of false positive rate in the context of unbal-
anced comparisons (Salmond et al., 2002; Scarpazza et al., 2013).
In addition the null effect of sample size suggests that, as long as a
balanced design is employed, the number of subjects in each exper-
imental group appears to have little or no impact on false positive
rate. Again, this observation is in contrast with our previous ﬁnd-
ing that sample size moderates false positive rate in the context of
single case VBM. Finally, the null effect of modulation suggests that
false positive rates are comparable for modulated and unmodulated
data, in contrast with our previous observation of higher false pos-
itive rates for unmodulated relative to modulated data in single
case VBM (Scarpazza et al., 2013). Taken collectively, these results
are consistent with the notion that VBM with balanced designs is
robust against violation of the assumption of normality, regardless
of the degree of smoothing, the sample size and the use of modula-
tion. However, the non-signiﬁcant effects of degree of smoothing,
sample size and modulation might also be explained by the very
small number of false positive effects in the present investigation
relative to our previous study (Scarpazza et al., 2013), which may
have resulted in reduced statistical sensitivity to these variables of
interest.
In contrast with our third hypothesis, we found that signiﬁcant
differences were randomly distributed across the whole cortex; for
example, the greater number of false positives in the frontal lobe
relative to other lobes could be explained in terms of the former
being larger than the latter. This is inconsistent with our previ-
ous report of a higher proportion of false positives in frontal and
temporal regions in the context of single case VBM (Scarpazza
et al., 2013). We  speculate that greater individual variability in
frontal and temporal cortices (Semendeferi et al., 1997) may  result
in greater violation of the assumption of normality in these regions,
and that this is a concern in the context of single case VBM but not
when groups of equal size are compared.
A limitation of the present study is that the statistical com-
parisons carried out within each data set were not completely
independent, as the same subject could be present in more than
one statistical comparison as a result of the repeated randomiza-
tion process used to create each group. However, there is no reason
to believe that this led to a systematic bias in our estimation of
false positive rates. A second limitation is that we investigated
false positive rates for a limited range of sample sizes (n = 8, 12, 16)
and smoothing kernels (4 mm,  8 mm and 12 mm); however, these
parameters were chosen based on the existing literature (Friston
et al., 1999; Friston, 2012; Salmond et al., 2002; Scarpazza et al.,
2013). The exploration of a larger range of parameters was outside
the scope of the present investigation and would require greater
much computational resources.
In conclusion, the present investigation provides empirical evi-
dence that, in VBM studies employing a balanced design, the
likelihood of detecting a signiﬁcant difference is not higher than
expected. This was replicated in two  independent data sets, and did
not appear to be inﬂuenced by the degree of smoothing, sample size
or modulation. These results provide reassurance that VBM stud-
ies comparing groups of equal size are not vulnerable to the higher
than expected false positive rates evident in single case VBM. It fol-
lows that non parametric statistics may  be indicated in the context
of single case VBM but are not required in VBM studies employing
a balanced design. A ﬁnal consideration is that the present investi-
gation used two  freely available data sets from the NITRC database;
we believe that this well illustrates the potential of sharing large
data sets for accelerating research about the human brain.
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